The nuclear receptor superfamily and drug discovery
被引:117
作者:
Moore, John T.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Discovery Res, Dept High Throughout Biol, Res Triangle Pk, NC 27709 USAGlaxoSmithKline Discovery Res, Dept High Throughout Biol, Res Triangle Pk, NC 27709 USA
Moore, John T.
[1
]
Collins, Jon L.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Discovery Res, Dept High Throughout Biol, Res Triangle Pk, NC 27709 USAGlaxoSmithKline Discovery Res, Dept High Throughout Biol, Res Triangle Pk, NC 27709 USA
Collins, Jon L.
[1
]
Pearce, Kenneth H.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Discovery Res, Dept High Throughout Biol, Res Triangle Pk, NC 27709 USAGlaxoSmithKline Discovery Res, Dept High Throughout Biol, Res Triangle Pk, NC 27709 USA
Pearce, Kenneth H.
[1
]
机构:
[1] GlaxoSmithKline Discovery Res, Dept High Throughout Biol, Res Triangle Pk, NC 27709 USA
Drug design;
Gene expression;
Inhibitors;
Medicinal chemistry;
Receptors;
D O I:
10.1002/cmdc.200600006
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Targeting the nuclear receptors: The ligand-binding domain of the glucocorticoid receptor (ribbon) bound with the ligand, dexamethasone (space-filling) is just one of the many pictures that are becoming clearer in the field of nuclear receptor (NR) research. Recent developments in drug discovery show great promise for the treatment of many NR-related diseases.